跳至主要内容
临床试验/NL-OMON48227
NL-OMON48227已完成4 期

Early effects of Vaccine Immunisation - Early Vaccine Immunization- study

RIVM0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Part I and Part II:
  • Healthy, pre-menopausal women who have not been vaccinated against HPV yet and
  • are seronegative for high-risk HPV vaccine types

排除标准

  • Part I and II:Medical conditions that will severely affect immunological
  • responses to
  • vaccinations, such as, but not limited to, cancer or an immune disorder.
  • Vaccination should be postponed during any illness with fever >38.5°C
  • until the fever has disappeared.
  • An additional HPVvaccination during the study.
  • Coagulation disorder and/or anticoagulant medication.
  • Be or have been under immunosuppressive medical treatment, like
  • cytostatics, high-dose corticosteroids, immune globulins, blood or
  • plasma transfusions that might interfere with the results of the study
  • (within the previous 3 months)., Had experienced a previous severe adverse
  • reaction to any vaccine.
  • Being pregnant
  • Participating in another vaccine/ medicine study

研究者

发起方
RIVM

相似试验